- Išsiųsime per 10–14 d.d.
/https://libri-media.knygos-static.lt/40e21c93-458c-4ba7-ab74-c1d5e8b4e30f/1)
- Autorius: John Carreyrou
- Leidėjas: Random House LCC US
- Metai: 2020
- Puslapiai: 368
- ISBN-10: 0525431993
- ISBN-13: 9780525431992
- Formatas: 13 x 20 x 2.2 cm, minkšti viršeliai
- Kalba: Anglų
- Extra -15 % nuolaida šiai knygai su kodu: ENG15
Atsiliepimai
Aprašymas
***A National Bestseller***
One of the Best Books of 2018: NPR • New York Times Book Review, Inc. • TIME • Wall Street Journal • Washington Post
"Chilling…Reads like a West Coast version of All the President's Men." -The New York Times Book Review
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
EXTRA 15 % nuolaida
Kupono kodas: ENG15
Akcija baigiasi už 09:44:29
Nuolaidos kodas galioja perkant nuo 10 €. Nuolaidos nesumuojamos.
- Autorius: John Carreyrou
- Leidėjas: Random House LCC US
- Metai: 2020
- Puslapiai: 368
- ISBN-10: 0525431993
- ISBN-13: 9780525431992
- Formatas: 13 x 20 x 2.2 cm, minkšti viršeliai
- Kalba: Anglų
***A National Bestseller***
One of the Best Books of 2018: NPR • New York Times Book Review, Inc. • TIME • Wall Street Journal • Washington Post
"Chilling…Reads like a West Coast version of All the President's Men." -The New York Times Book Review
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Atsiliepimai